496 related articles for article (PubMed ID: 30723155)
1. WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition.
Deng W; Fernandez A; McLaughlin SL; Klinke DJ
J Biol Chem; 2019 Apr; 294(14):5261-5280. PubMed ID: 30723155
[TBL] [Abstract][Full Text] [Related]
2. WISP1 aggravates cell metastatic potential by abrogating TGF-
Song D; Wang L; Su K; Wu H; Li J
Exp Biol Med (Maywood); 2021 Jun; 246(11):1244-1252. PubMed ID: 33593111
[TBL] [Abstract][Full Text] [Related]
3. WISP1 silencing confers protection against epithelial-mesenchymal transition of renal tubular epithelial cells in rats via inactivation of the wnt/β-catenin signaling pathway in uremia.
Chen YZ; Sun DQ; Zheng Y; Zheng GK; Chen RQ; Lin M; Huang LF; Huang C; Song D; Wu BQ
J Cell Physiol; 2019 Jun; 234(6):9673-9686. PubMed ID: 30556898
[TBL] [Abstract][Full Text] [Related]
4. WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer.
Chiang KC; Yeh CN; Chung LC; Feng TH; Sun CC; Chen MF; Jan YY; Yeh TS; Chen SC; Juang HH
Sci Rep; 2015 Mar; 5():8686. PubMed ID: 25732125
[TBL] [Abstract][Full Text] [Related]
5. Association of Wnt1-inducible signaling pathway protein-1 with the proliferation, migration and invasion in gastric cancer cells.
Jia S; Qu T; Feng M; Ji K; Li Z; Jiang W; Ji J
Tumour Biol; 2017 Jun; 39(6):1010428317699755. PubMed ID: 28618940
[TBL] [Abstract][Full Text] [Related]
6. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
[TBL] [Abstract][Full Text] [Related]
7. WNT1-inducible signalling pathway protein 1 stabilizes atherosclerotic plaques in apolipoprotein-E-deficient mice via the focal adhesion kinase/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase pathway.
Liu D; Zhang M; Tian J; Gao M; Liu M; Fu X; Jin T; Pan J; Chen F; An F
J Hypertens; 2022 Sep; 40(9):1666-1681. PubMed ID: 35881419
[TBL] [Abstract][Full Text] [Related]
8. Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma.
Tao W; Chu C; Zhou W; Huang Z; Zhai K; Fang X; Huang Q; Zhang A; Wang X; Yu X; Huang H; Wu Q; Sloan AE; Yu JS; Li X; Stark GR; Rich JN; Bao S
Nat Commun; 2020 Jun; 11(1):3015. PubMed ID: 32541784
[TBL] [Abstract][Full Text] [Related]
9. WISP1/CCN4 inhibits adipocyte differentiation through repression of PPARγ activity.
Ferrand N; Béreziat V; Moldes M; Zaoui M; Larsen AK; Sabbah M
Sci Rep; 2017 May; 7(1):1749. PubMed ID: 28496206
[TBL] [Abstract][Full Text] [Related]
10. Matricellular Protein WISP2 Is an Endogenous Inhibitor of Collagen Linearization and Cancer Metastasis.
Janjanam J; Pano G; Wang R; Minden-Birkenmaier BA; Breeze-Jones H; Baker E; Garcin C; Clayton G; Shirinifard A; Zaske AM; Finkelstein D; Labelle M
Cancer Res; 2021 Nov; 81(22):5666-5677. PubMed ID: 34385183
[TBL] [Abstract][Full Text] [Related]
11. CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): a focus on its role in cancer.
Gurbuz I; Chiquet-Ehrismann R
Int J Biochem Cell Biol; 2015 May; 62():142-6. PubMed ID: 25794425
[TBL] [Abstract][Full Text] [Related]
12. Identification of WISP1 as a novel oncogene in glioblastoma.
Jing D; Zhang Q; Yu H; Zhao Y; Shen L
Int J Oncol; 2017 Oct; 51(4):1261-1270. PubMed ID: 28902353
[TBL] [Abstract][Full Text] [Related]
13. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
14. Cell Communication Network Factor 4 (CCN4/WISP1) Shifts Melanoma Cells from a Fragile Proliferative State to a Resilient Metastatic State.
Deng W; Fernandez A; McLaughlin SL; Klinke DJ
Cell Mol Bioeng; 2020 Feb; 13(1):45-60. PubMed ID: 32030107
[TBL] [Abstract][Full Text] [Related]
15. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
16. WISP1 overexpression promotes proliferation and migration of human vascular smooth muscle cells via AKT signaling pathway.
Lu S; Liu H; Lu L; Wan H; Lin Z; Qian K; Yao X; Chen Q; Liu W; Yan J; Liu Z
Eur J Pharmacol; 2016 Oct; 788():90-97. PubMed ID: 27321870
[TBL] [Abstract][Full Text] [Related]
17. The tumor cell-secreted matricellular protein WISP1 drives pro-metastatic collagen linearization.
Jia H; Janjanam J; Wu SC; Wang R; Pano G; Celestine M; Martinot O; Breeze-Jones H; Clayton G; Garcin C; Shirinifard A; Zaske AM; Finkelstein D; Labelle M
EMBO J; 2019 Aug; 38(16):e101302. PubMed ID: 31294477
[TBL] [Abstract][Full Text] [Related]
18. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
19. PTEN Insufficiency Increases Breast Cancer Cell Metastasis In Vitro and In Vivo in a Xenograft Zebrafish Model.
Chiang KC; Hsu SY; Lin SJ; Yeh CN; Pang JH; Wang SY; Hsu JT; Yeh TS; Chen LW; Kuo SF; Cheng YC; Juang HH
Anticancer Res; 2016 Aug; 36(8):3997-4005. PubMed ID: 27466505
[TBL] [Abstract][Full Text] [Related]
20. PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells.
Perumal E; So Youn K; Sun S; Seung-Hyun J; Suji M; Jieying L; Yeun-Jun C
Lung Cancer; 2019 Apr; 130():25-34. PubMed ID: 30885348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
